[
  {
    "ts": "2025-09-29T16:41:22+00:00",
    "headline": "Abbott Laboratories (ABT): A Healthcare Leader Offering Dividend Value and Growth",
    "summary": "Abbott Laboratories (NYSE:ABT) is included among the 11 Best Value Dividend Stocks to Buy Now. Abbott Laboratories (NYSE:ABT) produces a wide range of healthcare products and medical devices, with its business divided into four main areas: established pharmaceuticals, diagnostics, nutrition, and medical devices. On September 19, Abbott Laboratories (NYSE:ABT) declared a quarterly dividend of $0.59 […]",
    "url": "https://finance.yahoo.com/news/abbott-laboratories-abt-healthcare-leader-164122432.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "03322d71-c3bf-3c67-a3b8-50a31364bb89",
      "content": {
        "id": "03322d71-c3bf-3c67-a3b8-50a31364bb89",
        "contentType": "STORY",
        "title": "Abbott Laboratories (ABT): A Healthcare Leader Offering Dividend Value and Growth",
        "description": "",
        "summary": "Abbott Laboratories (NYSE:ABT) is included among the 11 Best Value Dividend Stocks to Buy Now. Abbott Laboratories (NYSE:ABT) produces a wide range of healthcare products and medical devices, with its business divided into four main areas: established pharmaceuticals, diagnostics, nutrition, and medical devices. On September 19, Abbott Laboratories (NYSE:ABT) declared a quarterly dividend of $0.59 […]",
        "pubDate": "2025-09-29T16:41:22Z",
        "displayTime": "2025-09-29T16:41:22Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/3774069e75160f3491e217a8adc68902",
          "originalWidth": 580,
          "originalHeight": 387,
          "caption": "Abbott Laboratories (ABT): A Healthcare Leader Offering Dividend Value and Growth",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/t6RCH8PBlviwVdgmKACcLw--~B/aD0zODc7dz01ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/3774069e75160f3491e217a8adc68902.cf.webp",
              "width": 580,
              "height": 387,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jo4VFE.womibB84sqffwDg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/3774069e75160f3491e217a8adc68902.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbott-laboratories-abt-healthcare-leader-164122432.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbott-laboratories-abt-healthcare-leader-164122432.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-29T13:32:35+00:00",
    "headline": "Synlait Milk agrees North Island asset sale to Abbott Laboratories",
    "summary": "The assets, including the Pokeno factory, amount to around half of Synlait’s average market capitalisation.",
    "url": "https://www.just-food.com/news/synlait-milk-agrees-north-island-asset-sale-to-abbott-laboratories/",
    "source": "Just Food",
    "provider": "yfinance",
    "raw": {
      "id": "58cc3b64-dab8-3caf-bd08-79b671e2ce24",
      "content": {
        "id": "58cc3b64-dab8-3caf-bd08-79b671e2ce24",
        "contentType": "STORY",
        "title": "Synlait Milk agrees North Island asset sale to Abbott Laboratories",
        "description": "",
        "summary": "The assets, including the Pokeno factory, amount to around half of Synlait’s average market capitalisation.",
        "pubDate": "2025-09-29T13:32:35Z",
        "displayTime": "2025-09-29T13:32:35Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/just_food_692/66b35e2c5d86a509aedd56f1d0c78ea9",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/W39HFzqxfFEyP8ZIDxjCQg--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/just_food_692/66b35e2c5d86a509aedd56f1d0c78ea9.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/s8xILJDq3ifR4Bzw4vqVFQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/just_food_692/66b35e2c5d86a509aedd56f1d0c78ea9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Just Food",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.just-food.com/news/synlait-milk-agrees-north-island-asset-sale-to-abbott-laboratories/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/synlait-milk-agrees-north-island-133235110.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SML.NZ"
            },
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-29T13:00:03+00:00",
    "headline": "Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It",
    "summary": "Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
    "url": "https://finance.yahoo.com/news/abbott-laboratories-abt-trending-stock-130003209.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "38ed1dcf-96a7-36a7-a588-fec2f880a347",
      "content": {
        "id": "38ed1dcf-96a7-36a7-a588-fec2f880a347",
        "contentType": "STORY",
        "title": "Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It",
        "description": "",
        "summary": "Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
        "pubDate": "2025-09-29T13:00:03Z",
        "displayTime": "2025-09-29T13:00:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/ac90b3d74679f6d01a122aa033d8a9a4",
          "originalWidth": 900,
          "originalHeight": 600,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vqy2StQrekYiw3wwFUCZ6A--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ac90b3d74679f6d01a122aa033d8a9a4.cf.webp",
              "width": 900,
              "height": 600,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/N1J8mAJyPZolYBef44MAwg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ac90b3d74679f6d01a122aa033d8a9a4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbott-laboratories-abt-trending-stock-130003209.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbott-laboratories-abt-trending-stock-130003209.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-29T12:00:00+00:00",
    "headline": "Abbott's Dissolving Stent Receives Health Canada Approval for Treating Blocked Arteries Below-the-Knee",
    "summary": "Abbott (NYSE: ABT) today announced that Health Canada has authorized the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a first-of-its kind treatment innovation for people with chronic limb threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug, everolimus, to support vessel healing prior to completely dissolving.",
    "url": "https://finance.yahoo.com/news/abbotts-dissolving-stent-receives-health-120000854.html",
    "source": "CNW Group",
    "provider": "yfinance",
    "raw": {
      "id": "c53ffb7c-ecd5-3ad1-b786-76825715fa91",
      "content": {
        "id": "c53ffb7c-ecd5-3ad1-b786-76825715fa91",
        "contentType": "STORY",
        "title": "Abbott's Dissolving Stent Receives Health Canada Approval for Treating Blocked Arteries Below-the-Knee",
        "description": "",
        "summary": "Abbott (NYSE: ABT) today announced that Health Canada has authorized the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a first-of-its kind treatment innovation for people with chronic limb threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug, everolimus, to support vessel healing prior to completely dissolving.",
        "pubDate": "2025-09-29T12:00:00Z",
        "displayTime": "2025-09-29T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/cnwgroup.com/665c2ad7bc5ec6e690f6dfd549101ceb",
          "originalWidth": 400,
          "originalHeight": 209,
          "caption": "ABBOTT'S DISSOLVING STENT RECEIVES HEALTH CANADA APPROVAL FOR TREATING BLOCKED ARTERIES BELOW-THE-KNEE.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dbxQknAv76XrH..gR6HLSg--~B/aD0yMDk7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/cnwgroup.com/665c2ad7bc5ec6e690f6dfd549101ceb.cf.webp",
              "width": 400,
              "height": 209,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IpHnfBkVkO1PFT9hhClw1w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/cnwgroup.com/665c2ad7bc5ec6e690f6dfd549101ceb.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "CNW Group",
          "url": "http://www.newswire.ca/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbotts-dissolving-stent-receives-health-120000854.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbotts-dissolving-stent-receives-health-120000854.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-29T09:46:58+00:00",
    "headline": "What to Expect From Abbott Laboratories' Next Quarterly Earnings Report",
    "summary": "Abbott Laboratories will release its third-quarter earnings next month, and analysts anticipate a single-digit bottom-line growth.",
    "url": "https://www.barchart.com/story/news/35095042/what-to-expect-from-abbott-laboratories-next-quarterly-earnings-report",
    "source": "Barchart",
    "provider": "yfinance",
    "raw": {
      "id": "fe513afc-c833-3469-8d4b-27ca623ced4e",
      "content": {
        "id": "fe513afc-c833-3469-8d4b-27ca623ced4e",
        "contentType": "STORY",
        "title": "What to Expect From Abbott Laboratories' Next Quarterly Earnings Report",
        "description": "",
        "summary": "Abbott Laboratories will release its third-quarter earnings next month, and analysts anticipate a single-digit bottom-line growth.",
        "pubDate": "2025-09-29T09:46:58Z",
        "displayTime": "2025-09-29T09:46:58Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/barchart_com_477/6ba9ef5a0993c28c963073d39a3d6d3c",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "Abbott Laboratories vials and Logo-by Melniov Dmitriy via Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BsAI7U54QArX4400Dhb9WQ--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/barchart_com_477/6ba9ef5a0993c28c963073d39a3d6d3c.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wwvTNTR3XHJgruTgSxuuOw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/barchart_com_477/6ba9ef5a0993c28c963073d39a3d6d3c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barchart",
          "url": "https://www.barchart.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barchart.com/story/news/35095042/what-to-expect-from-abbott-laboratories-next-quarterly-earnings-report",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/expect-abbott-laboratories-next-quarterly-094658867.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]